Press Releases by Category Health & Medicine
US Urology Devices Market 2024 Size, Industry Trends and Forecast to 2031
US Urology Devices Market Size And Latest Trends, Analysis 2024:
Cognate Life Sciences has recently published Latest Report, " US Urology Devices Market (2024-2031) " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. US Urology Devices market report is a valuable source for the best market and business solutions for US Urology Devices industry in this rapidly altering…
Squalene Market is Expected to Boom in Coming Years by 2030 | Amyris, Inc., ARIS …
The global squalene industry generated $114.5 million in 2020, and is estimated to reach $241.6 million by 2030, witnessing a CAGR of 7.8% from 2021 to 2030.
Allied Market Research published a report, titled, "Squalene Market by Source (Animal, Vegetable, and Synthetic Biotechnology), End Use Industry (Cosmetics, Nutraceuticals, and Healthcare): Global Opportunity Analysis and Industry Forecast, 2021-2030." Squalene is a colorless, oily triterpene hydrocarbon that is found in many animals and plants, including sharks, olives,…
NA Medical Robots Market 2024 Size, Industry Trends and Forecast to 2031
NA Medical Robots Market Size And Latest Trends, Analysis 2024:
Cognate Life Sciences has recently published Latest Report, " NA Medical Robots Market (2024-2031) " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. NA Medical Robots market report is a valuable source for the best market and business solutions for NA Medical Robots industry in this rapidly altering…
Chile Menopause Drugs Market 2024 Size, Industry Trends and Forecast to 2031
Chile Menopause Drugs Market Size And Latest Trends, Analysis 2024:
Cognate Life Sciences has recently published Latest Report, " Chile Menopause Drugs Market (2024-2031) " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. Chile Menopause Drugs market report is a valuable source for the best market and business solutions for Chile Menopause Drugs industry in this rapidly altering…
Hearing Loop Market Analysis, Size, Share, Trends, Growth, And Forecast 2024-203 …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Hearing Loop Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The hearing loop market size has grown strongly in recent years. It…
General Medical And Surgical Hospitals Market Report 2024 | Leading Players: May …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through General Medical And Surgical Hospitals Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The general medical and surgical hospitals market size has…
Digital Diabetes Management Market | $17,118.7 Million | CAGR of 22.5% to 2026
𝐈𝐧 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥𝐦 𝐨𝐟 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐢𝐭𝐧𝐞𝐬𝐬𝐞𝐝 𝐚 𝐫𝐞𝐦𝐚𝐫𝐤𝐚𝐛𝐥𝐞 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 $3,375.8 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐲𝐞𝐚𝐫 2018. 𝐒𝐭𝐞𝐚𝐝𝐢𝐥𝐲 𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐧𝐠, 𝐭𝐡𝐢𝐬 𝐬𝐞𝐜𝐭𝐨𝐫 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐬𝐨𝐚𝐫 𝐭𝐨 𝐧𝐞𝐰 𝐡𝐞𝐢𝐠𝐡𝐭𝐬, 𝐫𝐞𝐚𝐜𝐡𝐢𝐧𝐠 𝐚 𝐬𝐭𝐚𝐠𝐠𝐞𝐫𝐢𝐧𝐠 $17,118.7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝐭𝐡𝐞 𝐲𝐞𝐚𝐫 2026. 𝐖𝐢𝐭𝐡 𝐚𝐧 𝐢𝐦𝐩𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 22.5% 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 2019 𝐚𝐧𝐝 2026, this industry showcases its potential for substantial expansion and innovation. As technology continues to revolutionize the…
Surgical Lights Market | $3.8 Billion | with a 4.5% CAGR to 2026
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐥𝐢𝐠𝐡𝐭𝐢𝐧𝐠 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐠𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐫𝐞𝐜𝐞𝐧𝐭 𝐲𝐞𝐚𝐫𝐬. 𝐈𝐧 2018, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐟𝐨𝐫 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐥𝐢𝐠𝐡𝐭𝐬 𝐫𝐞𝐚𝐜𝐡𝐞𝐝 𝐚 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 $2,717.5 𝐦𝐢𝐥𝐥𝐢𝐨𝐧. 𝐇𝐨𝐰𝐞𝐯𝐞𝐫, 𝐰𝐢𝐭𝐡 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐝 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐝𝐞𝐦𝐚𝐧𝐝, 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐰𝐢𝐭𝐧𝐞𝐬𝐬 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧, 𝐫𝐞𝐚𝐜𝐡𝐢𝐧𝐠 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 $3,838 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝐭𝐡𝐞 𝐲𝐞𝐚𝐫 2026. 𝐓𝐡𝐢𝐬 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐬 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 4.5% 𝐟𝐫𝐨𝐦 2019 𝐭𝐨 2026.
Surgical lights, also known as…
Disposable Syringes Market | $8,113.7 Million | CAGR of 5.1% to 2026
The global market for disposable syringes experienced significant growth in recent years, and this trend is expected to continue into the future. In 2018, the market size was estimated to be $5,450 million, but projections indicate that it will reach a substantial value of $8,113.7 million by the end of 2026. This represents a compound annual growth rate (CAGR) of 5.1% from 2019 to 2026.
The growth of the disposable syringes…
Pharmaceutical Drug Delivery Market | $1,733 Billion | 4.7% CAGR
The pharmaceutical drug delivery market, a rapidly growing sector, witnessed remarkable growth in recent years. In 2018, the market's value stood at an impressive $1,200 billion. Projections indicate that this upward trend will continue, with expectations pointing towards a substantial increase to $1,733 billion by 2026. This significant surge represents a compound annual growth rate (CAGR) of 4.7% from 2019 to 2026. These figures underscore the remarkable potential and promising…
Neurology Devices Market | $27.2 billion | Growing at a CAGR of 8.1% from 2024 t …
The neurology devices market, an innovative and rapidly evolving sector, demonstrated remarkable growth over the past decade. Starting from a valuation of $12.6 billion in 2021, this dynamic industry is projected to achieve significant milestones, with an estimated value of $27.2 billion by the year 2031. A compound annual growth rate (CAGR) of 8.1% is anticipated between the years 2022 and 2031, signaling robust expansion and promising opportunities within the…
Irritable Bowel Syndrome Treatment Market | $2 Billion by 2026
The market for treating irritable bowel syndrome (IBS) has witnessed significant growth in recent years. In 2018, the estimated value of the IBS treatment market was $1,071 million. However, with increasing awareness and advancements in medical research, the market is projected to reach a staggering $2,012 million by 2026. This represents a remarkable compound annual growth rate (CAGR) of 8.2% during the forecast period from 2019 to 2026.
Irritable bowel syndrome…
Premenstrual Syndrome Treatment Market | $1.5 Billion by 2026 | 3.7% CAGR
Premenstrual syndrome (PMS) treatment market has witnessed exceptional growth over the years. With a robust valuation of $1,129 million in 2018, this dynamic market is poised to soar even higher, reaching an estimated value of $1,516 million by 2026. This remarkable projection reflects a steady compound annual growth rate (CAGR) of 3.7% from 2019 to 2026, underlining the increasing demand for effective PMS treatments.
The growth and success of the PMS…
Non-Alcoholic Steatohepatitis Pipeline Report, 2024 Updates : In-depth Analysis …
Non-Alcoholic Steatohepatitis (NASH) Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Alcoholic Steatohepatitis pipeline constitutes 100+ key companies continuously working towards developing 150+ Non-Alcoholic Steatohepatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Non-Alcoholic Steatohepatitis Pipeline…
Antihyperlipidemic Drugs Market | $16.9 Billion by 2026
The antihyperlipidemic drugs market experienced remarkable growth, with a valuation of $9,456 million in 2018. This upward trend is anticipated to continue, projecting a substantial surge to $16,865 million by 2026. An impressive compound annual growth rate (CAGR) of 7.5% is expected from 2019 to 2026, underlining the industry's potential for expansion and advancement in the coming years.
Antihyperlipidemic drugs are specifically designed to address hyperlipidemia. There are various types of…
Triple Negative Breast Cancer Pipeline Assessment | In-depth Insights into the E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Triple Negative Breast Cancer pipeline constitutes 75+ key companies continuously working towards developing 80+ Triple Negative Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Triple Negative Breast Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Idiopathic Pulmonary Fibrosis Pipeline Drugs Analysis Report, 2024 Updates: FDA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 80+ key companies continuously working towards developing 100+ Idiopathic Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Idiopathic Pulmonary Fibrosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Idiopathic Pulmonary…
Hybrid Operating Room Market | $1,804 Million by 2026
In the realm of cutting-edge medical advancements, the hybrid operating room market emerged as a beacon of progress, commanding significant attention and financial growth. Embarking on an extraordinary trajectory, this market, valued at $744 million in 2018, has set its sights on reaching the zenith of $1,804 million by 2026. Astoundingly, this ambitious journey is anticipated to be fueled by an impressive compound annual growth rate (CAGR) of 11.7% from…
Epilepsy Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Epilepsy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Epilepsy Market.
The Epilepsy Pipeline report embraces in-depth…
Diabetic Retinopathy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Retinopathy pipeline constitutes 50+ key companies continuously working towards developing 55+ Diabetic Retinopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Diabetic Retinopathy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Retinopathy Market.
The Diabetic…
Immunosuppressants Market | $42,511.37 Million | CAGR of 14.7% by 2026
The market for immunosuppressants experienced significant growth in recent years and is projected to continue its upward trajectory in the coming years. Starting with a valuation of $13,890.0 million in 2018, it is anticipated to soar to a remarkable $42,511.37 million by 2026, reflecting a robust compound annual growth rate (CAGR) of 14.7% from 2019 to 2026. This substantial expansion underscores the increasing demand for immunosuppressant drugs and highlights their…
Metastatic Melanoma Pipeline, FDA Approvals, Clinical Trials Developments and Co …
DelveInsight's, "Metastatic Melanoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Melanoma pipeline landscape. It covers the Metastatic Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Melanoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Metastatic…
Relapsed or Refractory Myelodysplastic Syndrome Pipeline, FDA Approvals, Clinica …
DelveInsight's, "Relapsed or Refractory Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Relapsed or Refractory Myelodysplastic Syndrome pipeline landscape. It covers the Relapsed or Refractory Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Relapsed or Refractory Myelodysplastic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…
Spinal Cord Injury Pipeline, FDA Approvals, Clinical Trials Developments and Com …
DelveInsight's, "Spinal Cord Injury Pipeline Insight 2024" report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in the Spinal Cord Injury pipeline landscape. It covers the Spinal Cord Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Spinal Cord Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Crohn's Disease Pipeline, FDA Approvals, Clinical Trials Developments and Compan …
DelveInsight's, "Crohn's Disease Pipeline Insight, 2024" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the Crohn's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Crohn's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Crohn's Disease…
General Anesthesia Drugs Market | $7.7 billion | Growing at a CAGR of 3.5% from …
Emerging as a crucial component of modern medical procedures, the global market for general anesthesia drugs showcased remarkable growth in recent years. In 2021, the market size stood at an impressive $5.4 billion, and it is anticipated to ascend to new heights, reaching a value of $7.7 billion by the year 2031. This growth trajectory translates to a Compound Annual Growth Rate (CAGR) of 3.5% during the period spanning from…
Obesity intervention devices market | $407.6 million | Growing at a CAGR of 5.3% …
𝐓𝐡𝐞 𝐨𝐛𝐞𝐬𝐢𝐭𝐲 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐫𝐞𝐦𝐚𝐫𝐤𝐚𝐛𝐥𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐫𝐞𝐜𝐞𝐧𝐭 𝐲𝐞𝐚𝐫𝐬, 𝐰𝐢𝐭𝐡 𝐚 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 $243.2 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2021. 𝐓𝐡𝐢𝐬 𝐮𝐩𝐰𝐚𝐫𝐝 𝐭𝐫𝐚𝐣𝐞𝐜𝐭𝐨𝐫𝐲 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞, 𝐩𝐫𝐨𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $407.6 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2031. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐩𝐞𝐫𝐢𝐨𝐝 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 2022 𝐚𝐧𝐝 2031 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 5.3%.
Obesity intervention devices have emerged as a promising solution to address the global epidemic of obesity. These medical…
Upcoming Conference on Next - Gen Digital Pathology |21st-22nd March 2024 | Lond …
Integration of artificial intelligence (AI) and Machine learning algorithms into pathology workflows, heralding a new era of efficiency and accuracy at analysing pathology images, managing quality data & aiding pathologists in rapid and precise diagnoses.
We at MarketsandMarkets are extremely thrilled to announce our "MarketsandMarkets 2nd Annual Next-Gen Digital Pathology Conference" scheduled to be held on 21st - 22nd March 2024. The conference promises an immersive exploration into the future of…
Ophthalmic Viscoelastic Devices Market | $3,226 million | Registering a CAGR of …
In the realm of eye care, the ophthalmic viscoelastic devices (OVD) market displayed remarkable growth between 2018 and the projected year of 2026. Back in 2018, this market segment amassed a considerable sum of $2,332 million. However, its ascent does not stop there, as experts anticipate a significant surge in its value, reaching an impressive milestone of $3,226 million by 2026. This growth trajectory signifies a commendable compound annual growth…
Ulcerative Colitis Pipeline, FDA Approvals, Clinical Trials Developments, and Co …
DelveInsight's, "Ulcerative Colitis Pipeline Insight 2023" report provides comprehensive insights about 110+ companies and 110+ pipeline drugs in the Ulcerative Colitis pipeline landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Ulcerative…
laboratory equipment and disposables market | $53,273.02 million | Growing at a …
The market for laboratory equipment and disposables has experienced significant growth in recent years, with its value reaching $30,012.81 million in 2021 and projected to surge to $53,273.02 million by 2031, representing a remarkable compound annual growth rate (CAGR) of 5.9% from 2022 to 2031. This growth trajectory is driven by several factors, including the increasing demand for cutting-edge laboratory tools and consumables, driven by the complexity of research and…
Peanut Allergy Pipeline, FDA Approvals, Clinical Trials Developments, and Compan …
DelveInsight's, "Peanut Allergy Pipeline Insight, 2023," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Peanut Allergy pipeline landscape. It covers the Peanut Allergy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Peanut Allergy Pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Peanut…
Epilepsy Pipeline, FDA Approvals, Clinical Trials Developments and Companies 202 …
DelveInsight's, "Epilepsy Pipeline Insight, 2023" report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Epilepsy Pipeline Report
• DelveInsight's Epilepsy pipeline report…
Cell Therapy Market | $48,115.40 Million | CAGR of 25.6%
The domain of cell therapy is on the brink of significant expansion and evolution. In the year 2019, the market for cell therapy witnessed substantial advancement, achieving a notable valuation of $7,754.89 million. However, the future presents even more promising prospects, with projections indicating a surge to unprecedented levels, expected to reach a remarkable $48,115.40 million by 2027. This remarkable growth trajectory is anticipated to be driven by a notable…
Duchenne Muscular Dystrophy Pipeline, FDA Approvals, Clinical Trials Development …
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2023," report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Biliary Tract Cancers Pipeline, FDA Approvals, Clinical Trials Developments and …
DelveInsight's, "Biliary Tract Cancers Pipeline Insight, 2023," report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers pipeline landscape. It covers the Biliary Tract Cancers pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Biliary Tract Cancers pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Wet Age-Related Macular Degeneration Pipeline 2024
DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipeline landscape. It covers the Wet Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
PCSK9 Inhibitor Pipeline Insights Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the PCSK9 Inhibitor Pipeline Report, a detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, PCSK9 Inhibitor NDA approvals (if any),…
Hyperphosphatemia Pipeline Insight Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the Hyperphosphatemia Pipeline constitutes 15+ key companies continuously working towards developing 15+ Hyperphosphatemia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Hyperphosphatemia Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Hyperphosphatemia NDA approvals (if any), and product development activities comprising…
Hepatorenal Syndrome Pipeline Insights Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Hepatorenal Syndrome Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Hepatorenal Syndrome NDA approvals (if…
Parkinson's Disease Psychosis Pipeline Insight Report 2024 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Parkinson's disease Psychosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's Disease Psychosis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Parkinson's Disease Psychosis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any),…
Polystyrene Capacitors Market share, Market trends, and forecasts from 2024 to 2 …
Market Overview and Report Coverage
Polystyrene capacitors are a type of capacitors known for their high stability and low losses, making them ideal for precision applications in electronics such as audio equipment, instrumentation, and communication devices.
The current outlook for the Polystyrene Capacitors Market is positive, with steady growth expected in the coming years. The market is projected to grow at a CAGR of 4.20% during the forecasted period,…
Oral Mucositis Pipeline Insight Reports 2024 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ key companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Oral Mucositis Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Oral Mucositis NDA approvals (if any), and…
Analyzing the Bowel Management Systems Market: Trends, Growth Analysis, and Fore …
The global Bowel Management Systems Market has been witnessing a surge in demand driven by factors such as the rise in prevalence of fecal incontinence, the increase in the geriatric population, and the growing acceptance of bowel management products. This article provides a detailed overview of the market, including key segments, growth trends, major players, competitive landscape, market drivers, challenges, and future outlook.
Download Sample PDF Copy of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49794
Market Overview:
The…
Exploring Trends and Growth Opportunities in the Gynecology Devices Market: Anal …
The global gynecology devices market has witnessed substantial growth in recent years, driven by factors such as the rise in prevalence of gynecological diseases, increasing awareness about women's health, and advancements in medical technology. A comprehensive market research study reveals key insights into market size, growth trends, key players, competitive landscape, market drivers, challenges, opportunities, and future outlook.
Download Sample PDF Copy of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=53592
Market Drivers and Trends:
The market for gynecology…
Insights into the Veterinary Orthopedic Implant Market: Analysis, Growth Trends, …
The global veterinary orthopedic implant market is witnessing significant growth, fueled by various factors such as increased pet ownership, rising expenditure on animal healthcare, and technological advancements in orthopedic implants.
Download Sample PDF Copy of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=53937
Impact of COVID-19 Pandemic:
The COVID-19 pandemic has disrupted various industries, including orthopedic implants manufacturing. Supply chain disruptions, labor shortages, and reduced end-consumer demand have affected market dynamics. However, governments' financial support and favorable policies for…
Examining the Dynamics of the Neonatal Intensive Care Respiratory Devices Market …
The global neonatal intensive care respiratory devices market is poised for significant growth between 2018 and 2026, driven by various factors such as the rising incidence of respiratory diseases in newborns and the increasing prevalence of preterm births. Here's an overview of
Download Sample PDF Copy of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54741
Demand for Respiratory Devices in Neonatal Care:
With the growing number of preterm births worldwide, there is a heightened need to enhance survival rates…
Unveiling Insights into the Vessel Sealing Devices Market: Analysis, Growth Tren …
The vessel sealing devices market is witnessing substantial growth and is projected to continue on an upward trajectory from 2021 to 2031. This report provides an in-depth analysis of various facets of the vessel sealing devices market, including market trends, growth drivers, key players, competitive landscape, market segmentation, and regional outlook.
Download Sample PDF Copy of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55227
Med-tech Companies Respond to COVID-19 Pandemic
In light of the global COVID-19 pandemic, there is…
QSYMIA (Phentermine- topiramate) Market Size and Share Analysis Across 7MM and C …
DelveInsight has released a comprehensive report titled "QSYMIA (Phentermine- topiramate) Market Forecast" offering a thorough examination and predictive insights into the QSYMIA (Phentermine- topiramate) market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The extensive report offers a thorough examination of the market potential and market share of QSYMIA (Phentermine- topiramate) in the therapeutics landscape…
IMCIVREE (Setmelanotide) Market Size and Share Analysis Across 7MM and Competiti …
DelveInsight has released a comprehensive report titled "IMCIVREE (Setmelanotide) Market Forecast" offering a thorough examination and predictive insights into the IMCIVREE (Setmelanotide) market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The extensive report offers a thorough examination of the market potential and market share of IMCIVREE (Setmelanotide) in the therapeutics landscape for Obesity across…
Go To Page: 71 72 73 74 75 76 77 78 79 80 711 712 713 714 715 716 717 718 719 720